APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mental Illness Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mental Illness Drugs Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchMental Illness Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Mental Illness Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Mental Illness Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mental Illness Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Mental Illness Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Mental Illness Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mental Illness Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mental Illness Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mental Illness Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mental Illness Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mental Illness Drugs include Johnson and Johnson, Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mental Illness Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mental Illness Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Mental Illness Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mental Illness Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mental Illness Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mental Illness Drugs sales, projected growth trends, production technology, application and end-user industry.

Mental Illness Drugs Segment by Company

Johnson and Johnson

Eli Lilly

Pfizer

GlaxoSmithKline

AstraZeneca

Bristol-Myers Squibb

Mental Illness Drugs Segment by Type

Substance abuse treatments

Stimulants

Sleep disorder treatments

Cognitive disorders and dementia

Antidepressants

Antipsychotics

Antianxiety (anxiolyitcs)

Anti-seizure medications

Mental Illness Drugs Segment by Application

Drugstore

Hospital

Clinic

Mental Illness Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mental Illness Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mental Illness Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mental Illness Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mental Illness Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mental Illness Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mental Illness Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mental Illness Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Substance abuse treatments Major Manufacturers Table 3. Stimulants Major Manufacturers Table 4. Sleep disorder treatments Major Manufacturers Table 5. Cognitive disorders and dementia Major Manufacturers Table 6. Antidepressants Major Manufacturers Table 7. Antipsychotics Major Manufacturers Table 8. Antianxiety (anxiolyitcs) Major Manufacturers Table 9. Anti-seizure medications Major Manufacturers Table 10. Global Mental Illness Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Drugstore Major Manufacturers Table 12. Hospital Major Manufacturers Table 13. Clinic Major Manufacturers Table 14. Mental Illness Drugs Industry Trends Table 15. Mental Illness Drugs Industry Drivers Table 16. Mental Illness Drugs Industry Opportunities and Challenges Table 17. Mental Illness Drugs Industry Restraints Table 18. Global Mental Illness Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Mental Illness Drugs Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Mental Illness Drugs Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Mental Illness Drugs Revenue Market Share by Region (2021-2026) Table 22. Global Mental Illness Drugs Revenue Market Share by Region (2027-2032) Table 23. Global Mental Illness Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 24. Global Mental Illness Drugs Sales by Region (2021-2026) & (k units) Table 25. Global Mental Illness Drugs Sales by Region (2027-2032) & (k units) Table 26. Global Mental Illness Drugs Sales Market Share by Region (2021-2026) Table 27. Global Mental Illness Drugs Sales Market Share by Region (2027-2032) Table 28. Global Mental Illness Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Mental Illness Drugs Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Mental Illness Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Mental Illness Drugs Sales Market Share by Manufacturers (2021-2026) Table 32. Global Mental Illness Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 33. Global Mental Illness Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mental Illness Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Mental Illness Drugs Manufacturers, Product Type & Application Table 36. Global Mental Illness Drugs Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Mental Illness Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mental Illness Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Mental Illness Drugs Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Mental Illness Drugs Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Mental Illness Drugs Revenue Market Share by Type (2021-2026) Table 43. Global Mental Illness Drugs Revenue Market Share by Type (2027-2032) Table 44. Global Mental Illness Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 45. Global Mental Illness Drugs Sales by Type (2021-2026) & (k units) Table 46. Global Mental Illness Drugs Sales by Type (2027-2032) & (k units) Table 47. Global Mental Illness Drugs Sales Market Share by Type (2021-2026) Table 48. Global Mental Illness Drugs Sales Market Share by Type (2027-2032) Table 49. Global Mental Illness Drugs Price by Type (2021-2026) & (US$/unit) Table 50. Global Mental Illness Drugs Price by Type (2027-2032) & (US$/unit) Table 51. Global Mental Illness Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Mental Illness Drugs Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Mental Illness Drugs Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Mental Illness Drugs Revenue Market Share by Application (2021-2026) Table 55. Global Mental Illness Drugs Revenue Market Share by Application (2027-2032) Table 56. Global Mental Illness Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 57. Global Mental Illness Drugs Sales by Application (2021-2026) & (k units) Table 58. Global Mental Illness Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Mental Illness Drugs Sales Market Share by Application (2021-2026) Table 60. Global Mental Illness Drugs Sales Market Share by Application (2027-2032) Table 61. Global Mental Illness Drugs Price by Application (2021-2026) & (US$/unit) Table 62. Global Mental Illness Drugs Price by Application (2027-2032) & (US$/unit) Table 63. Johnson and Johnson Company Information Table 64. Johnson and Johnson Business Overview Table 65. Johnson and Johnson Mental Illness Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Johnson and Johnson Mental Illness Drugs Product Portfolio Table 67. Johnson and Johnson Recent Development Table 68. Eli Lilly Company Information Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Mental Illness Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Eli Lilly Mental Illness Drugs Product Portfolio Table 72. Eli Lilly Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Mental Illness Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pfizer Mental Illness Drugs Product Portfolio Table 77. Pfizer Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Mental Illness Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Mental Illness Drugs Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Mental Illness Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. AstraZeneca Mental Illness Drugs Product Portfolio Table 87. AstraZeneca Recent Development Table 88. Bristol-Myers Squibb Company Information Table 89. Bristol-Myers Squibb Business Overview Table 90. Bristol-Myers Squibb Mental Illness Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bristol-Myers Squibb Mental Illness Drugs Product Portfolio Table 92. Bristol-Myers Squibb Recent Development Table 93. North America Mental Illness Drugs Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Mental Illness Drugs Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Mental Illness Drugs Sales by Type (2021-2026) & (k units) Table 96. North America Mental Illness Drugs Sales by Type (2027-2032) & (k units) Table 97. North America Mental Illness Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 98. North America Mental Illness Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 99. North America Mental Illness Drugs Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Mental Illness Drugs Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Mental Illness Drugs Sales by Application (2021-2026) & (k units) Table 102. North America Mental Illness Drugs Sales by Application (2027-2032) & (k units) Table 103. North America Mental Illness Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 104. North America Mental Illness Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 105. North America Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Mental Illness Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Mental Illness Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 109. North America Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 110. North America Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 111. North America Mental Illness Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 112. North America Mental Illness Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 113. United States Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 114. Canada Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 115. Mexico Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 116. Europe Mental Illness Drugs Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Mental Illness Drugs Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Mental Illness Drugs Sales by Type (2021-2026) & (k units) Table 119. Europe Mental Illness Drugs Sales by Type (2027-2032) & (k units) Table 120. Europe Mental Illness Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 121. Europe Mental Illness Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 122. Europe Mental Illness Drugs Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Mental Illness Drugs Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Mental Illness Drugs Sales by Application (2021-2026) & (k units) Table 125. Europe Mental Illness Drugs Sales by Application (2027-2032) & (k units) Table 126. Europe Mental Illness Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 127. Europe Mental Illness Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 128. Europe Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Mental Illness Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Mental Illness Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 132. Europe Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 133. Europe Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 134. Europe Mental Illness Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 135. Europe Mental Illness Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 136. Germany Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 137. France Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 138. U.K. Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 139. Italy Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 140. Russia Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 141. Spain Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 144. Sweden Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 145. Poland Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 146. China Mental Illness Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. China Mental Illness Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. China Mental Illness Drugs Sales by Type (2021-2026) & (k units) Table 149. China Mental Illness Drugs Sales by Type (2027-2032) & (k units) Table 150. China Mental Illness Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 151. China Mental Illness Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 152. China Mental Illness Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. China Mental Illness Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. China Mental Illness Drugs Sales by Application (2021-2026) & (k units) Table 155. China Mental Illness Drugs Sales by Application (2027-2032) & (k units) Table 156. China Mental Illness Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 157. China Mental Illness Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Mental Illness Drugs Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Mental Illness Drugs Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Mental Illness Drugs Sales by Type (2021-2026) & (k units) Table 161. Asia Mental Illness Drugs Sales by Type (2027-2032) & (k units) Table 162. Asia Mental Illness Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 163. Asia Mental Illness Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 164. Asia Mental Illness Drugs Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Mental Illness Drugs Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Mental Illness Drugs Sales by Application (2021-2026) & (k units) Table 167. Asia Mental Illness Drugs Sales by Application (2027-2032) & (k units) Table 168. Asia Mental Illness Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 169. Asia Mental Illness Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 170. Asia Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Mental Illness Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Mental Illness Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. Asia Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 175. Asia Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 176. Asia Mental Illness Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 177. Asia Mental Illness Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 178. Japan Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 179. South Korea Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 180. India Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 181. Australia Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Mental Illness Drugs Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Mental Illness Drugs Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Mental Illness Drugs Sales by Type (2021-2026) & (k units) Table 187. SAMEA Mental Illness Drugs Sales by Type (2027-2032) & (k units) Table 188. SAMEA Mental Illness Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 189. SAMEA Mental Illness Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 190. SAMEA Mental Illness Drugs Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Mental Illness Drugs Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Mental Illness Drugs Sales by Application (2021-2026) & (k units) Table 193. SAMEA Mental Illness Drugs Sales by Application (2027-2032) & (k units) Table 194. SAMEA Mental Illness Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 195. SAMEA Mental Illness Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 196. SAMEA Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Mental Illness Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Mental Illness Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 200. SAMEA Mental Illness Drugs Sales by Country (2021-2026) & (k units) Table 201. SAMEA Mental Illness Drugs Sales by Country (2027-2032) & (k units) Table 202. SAMEA Mental Illness Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 203. SAMEA Mental Illness Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 204. Brazil Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 205. Argentina Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 206. Chile Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 207. Colombia Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 208. Peru Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 210. Israel Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 211. UAE Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 212. Turkey Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 213. Iran Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 214. Egypt Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Mental Illness Drugs Distributors List Table 218. Mental Illness Drugs Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Mental Illness Drugs Image Figure 2. Global Mental Illness Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mental Illness Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Substance abuse treatments Image Figure 5. Stimulants Image Figure 6. Sleep disorder treatments Image Figure 7. Cognitive disorders and dementia Image Figure 8. Antidepressants Image Figure 9. Antipsychotics Image Figure 10. Antianxiety (anxiolyitcs) Image Figure 11. Anti-seizure medications Image Figure 12. Global Mental Illness Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Mental Illness Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 14. Drugstore Image Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Global Mental Illness Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Mental Illness Drugs Revenue (2021-2032) & (US$ Million) Figure 19. Global Mental Illness Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Mental Illness Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Mental Illness Drugs Revenue Market Share by Region (2021-2032) Figure 22. Global Mental Illness Drugs Sales (2021-2032) & (k units) Figure 23. Global Mental Illness Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 24. Global Mental Illness Drugs Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Mental Illness Drugs Sales YoY (2021-2032) & (k units) Figure 26. Europe Mental Illness Drugs Sales YoY (2021-2032) & (k units) Figure 27. China Mental Illness Drugs Sales YoY (2021-2032) & (k units) Figure 28. Asia (Excluding China) Mental Illness Drugs Sales YoY (2021-2032) & (k units) Figure 29. South America, Middle East and Africa Mental Illness Drugs Sales YoY (2021-2032) & (k units) Figure 30. Global Mental Illness Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Mental Illness Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Mental Illness Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Mental Illness Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Mental Illness Drugs Revenue Market Share by Type (2021-2032) Figure 36. Global Mental Illness Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Mental Illness Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Mental Illness Drugs Sales Market Share by Type (2021-2032) Figure 39. Global Mental Illness Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Mental Illness Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Mental Illness Drugs Revenue Market Share by Application (2021-2032) Figure 42. Global Mental Illness Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 43. Global Mental Illness Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Mental Illness Drugs Sales Market Share by Application (2021-2032) Figure 45. North America Mental Illness Drugs Revenue Share by Type (2021-2032) Figure 46. North America Mental Illness Drugs Sales Share by Type (2021-2032) Figure 47. North America Mental Illness Drugs Revenue Share by Application (2021-2032) Figure 48. North America Mental Illness Drugs Sales Share by Application (2021-2032) Figure 49. North America Mental Illness Drugs Revenue Share by Country (2021-2032) Figure 50. North America Mental Illness Drugs Sales Share by Country (2021-2032) Figure 51. Europe Mental Illness Drugs Revenue Share by Type (2021-2032) Figure 52. Europe Mental Illness Drugs Sales Share by Type (2021-2032) Figure 53. Europe Mental Illness Drugs Revenue Share by Application (2021-2032) Figure 54. Europe Mental Illness Drugs Sales Share by Application (2021-2032) Figure 55. Europe Mental Illness Drugs Revenue Share by Country (2021-2032) Figure 56. Europe Mental Illness Drugs Sales Share by Country (2021-2032) Figure 57. China Mental Illness Drugs Revenue Share by Type (2021-2032) Figure 58. China Mental Illness Drugs Sales Share by Type (2021-2032) Figure 59. China Mental Illness Drugs Revenue Share by Application (2021-2032) Figure 60. China Mental Illness Drugs Sales Share by Application (2021-2032) Figure 61. Asia Mental Illness Drugs Revenue Share by Type (2021-2032) Figure 62. Asia Mental Illness Drugs Sales Share by Type (2021-2032) Figure 63. Asia Mental Illness Drugs Revenue Share by Application (2021-2032) Figure 64. Asia Mental Illness Drugs Sales Share by Application (2021-2032) Figure 65. Asia Mental Illness Drugs Revenue Share by Country (2021-2032) Figure 66. Asia Mental Illness Drugs Sales Share by Country (2021-2032) Figure 67. SAMEA Mental Illness Drugs Revenue Share by Type (2021-2032) Figure 68. SAMEA Mental Illness Drugs Sales Share by Type (2021-2032) Figure 69. SAMEA Mental Illness Drugs Revenue Share by Application (2021-2032) Figure 70. SAMEA Mental Illness Drugs Sales Share by Application (2021-2032) Figure 71. SAMEA Mental Illness Drugs Revenue Share by Country (2021-2032) Figure 72. SAMEA Mental Illness Drugs Sales Share by Country (2021-2032) Figure 73. Mental Illness Drugs Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Mental Illness Drugs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Substance abuse treatments
  • Stimulants
  • Sleep disorder treatments
  • Cognitive disorders and dementia
  • Antidepressants
  • Antipsychotics
  • Antianxiety (anxiolyitcs)
  • Anti-seizure medications
Applications
  • Drugstore
  • Hospital
  • Clinic
Companies covered
  • Johnson and Johnson
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mental Illness Drugs Market by Type
  3. 1.2.1 Global Mental Illness Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Substance abuse treatments
  5. 1.2.3 Stimulants
  6. 1.2.4 Sleep disorder treatments
  7. 1.2.5 Cognitive disorders and dementia
  8. 1.2.6 Antidepressants
  9. 1.2.7 Antipsychotics
  10. 1.2.8 Antianxiety (anxiolyitcs)
  11. 1.2.9 Anti-seizure medications
  12. 1.3 Mental Illness Drugs Market by Application
  13. 1.3.1 Global Mental Illness Drugs Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Drugstore
  15. 1.3.3 Hospital
  16. 1.3.4 Clinic
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Mental Illness Drugs Market Dynamics
  1. 2.1 Mental Illness Drugs Industry Trends
  2. 2.2 Mental Illness Drugs Industry Drivers
  3. 2.3 Mental Illness Drugs Industry Opportunities and Challenges
  4. 2.4 Mental Illness Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mental Illness Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mental Illness Drugs Revenue by Region
  3. 3.2.1 Global Mental Illness Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mental Illness Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Mental Illness Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Mental Illness Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mental Illness Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mental Illness Drugs Sales by Region
  9. 3.4.1 Global Mental Illness Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mental Illness Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Mental Illness Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Mental Illness Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mental Illness Drugs Revenue by Manufacturers
  2. 4.1.1 Global Mental Illness Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mental Illness Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mental Illness Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mental Illness Drugs Sales by Manufacturers
  6. 4.2.1 Global Mental Illness Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mental Illness Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mental Illness Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mental Illness Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mental Illness Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mental Illness Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mental Illness Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Mental Illness Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mental Illness Drugs Market CR5 and HHI
  16. 4.8.2 2025 Mental Illness Drugs Tier 1, Tier 2, and Tier 3
5 Mental Illness Drugs Market by Type
  1. 5.1 Global Mental Illness Drugs Revenue by Type
  2. 5.1.1 Global Mental Illness Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mental Illness Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mental Illness Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mental Illness Drugs Sales by Type
  6. 5.2.1 Global Mental Illness Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mental Illness Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Mental Illness Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mental Illness Drugs Price by Type
6 Mental Illness Drugs Market by Application
  1. 6.1 Global Mental Illness Drugs Revenue by Application
  2. 6.1.1 Global Mental Illness Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mental Illness Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mental Illness Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mental Illness Drugs Sales by Application
  6. 6.2.1 Global Mental Illness Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mental Illness Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Mental Illness Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mental Illness Drugs Price by Application
7 Company Profiles
  1. 7.1 Johnson and Johnson
  2. 7.1.1 Johnson and Johnson Company Information
  3. 7.1.2 Johnson and Johnson Business Overview
  4. 7.1.3 Johnson and Johnson Mental Illness Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson and Johnson Mental Illness Drugs Product Portfolio
  6. 7.1.5 Johnson and Johnson Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Mental Illness Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Mental Illness Drugs Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Mental Illness Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Mental Illness Drugs Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Mental Illness Drugs Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Mental Illness Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Mental Illness Drugs Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Bristol-Myers Squibb
  32. 7.6.1 Bristol-Myers Squibb Company Information
  33. 7.6.2 Bristol-Myers Squibb Business Overview
  34. 7.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol-Myers Squibb Mental Illness Drugs Product Portfolio
  36. 7.6.5 Bristol-Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Mental Illness Drugs Market Size by Type
  2. 8.1.1 North America Mental Illness Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Mental Illness Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Mental Illness Drugs Price by Type (2021-2032)
  5. 8.2 North America Mental Illness Drugs Market Size by Application
  6. 8.2.1 North America Mental Illness Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Mental Illness Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Mental Illness Drugs Price by Application (2021-2032)
  9. 8.3 North America Mental Illness Drugs Market Size by Country
  10. 8.3.1 North America Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mental Illness Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Mental Illness Drugs Market Size by Type
  2. 9.1.1 Europe Mental Illness Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mental Illness Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Mental Illness Drugs Price by Type (2021-2032)
  5. 9.2 Europe Mental Illness Drugs Market Size by Application
  6. 9.2.1 Europe Mental Illness Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mental Illness Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Mental Illness Drugs Price by Application (2021-2032)
  9. 9.3 Europe Mental Illness Drugs Market Size by Country
  10. 9.3.1 Europe Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mental Illness Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Mental Illness Drugs Market Size by Type
  2. 10.1.1 China Mental Illness Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Mental Illness Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Mental Illness Drugs Price by Type (2021-2032)
  5. 10.2 China Mental Illness Drugs Market Size by Application
  6. 10.2.1 China Mental Illness Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Mental Illness Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Mental Illness Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mental Illness Drugs Market Size by Type
  2. 11.1.1 Asia Mental Illness Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mental Illness Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Mental Illness Drugs Price by Type (2021-2032)
  5. 11.2 Asia Mental Illness Drugs Market Size by Application
  6. 11.2.1 Asia Mental Illness Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mental Illness Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Mental Illness Drugs Price by Application (2021-2032)
  9. 11.3 Asia Mental Illness Drugs Market Size by Country
  10. 11.3.1 Asia Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mental Illness Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mental Illness Drugs Market Size by Type
  2. 12.1.1 SAMEA Mental Illness Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mental Illness Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mental Illness Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Mental Illness Drugs Market Size by Application
  6. 12.2.1 SAMEA Mental Illness Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mental Illness Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mental Illness Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Mental Illness Drugs Market Size by Country
  10. 12.3.1 SAMEA Mental Illness Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mental Illness Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mental Illness Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mental Illness Drugs Value Chain Analysis
  2. 13.1.1 Mental Illness Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mental Illness Drugs Production Mode & Process
  6. 13.2 Mental Illness Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mental Illness Drugs Distributors
  9. 13.2.3 Mental Illness Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst